Terms: = Ovarian cancer AND POLE, POLE1, 5426, FLJ21434, DKFZp434F222, ENSG00000177084
171 results:
1. The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial.
Giudice E; Huang TT; Nair JR; Zurcher G; McCoy A; Nousome D; Radke MR; Swisher EM; Lipkowitz S; Ibanez K; Donohue D; Malys T; Lee MJ; Redd B; Levy E; Rastogi S; Sato N; Trepel JB; Lee JM
Nat Commun; 2024 Mar; 15(1):2805. PubMed ID: 38555285
[TBL] [Abstract] [Full Text] [Related]
2. Post molar choriocarcinoma with solitary renal metastasis in the absence of primary uterine tumor: a case report and review of the literature.
Geravandi M; Hajihashemi A; Adibi A; Habibi Tirtashi R
J Med Case Rep; 2024 Mar; 18(1):132. PubMed ID: 38553733
[TBL] [Abstract] [Full Text] [Related]
3. Integration of the Molecular Classification of Endometrial Carcinoma to Select Patients for Fertility Sparing Strategies.
Bani MA; Maulard A; Morice P; Chargari C; Genestie C
Anticancer Res; 2024 Feb; 44(2):445-452. PubMed ID: 38307584
[TBL] [Abstract] [Full Text] [Related]
4. Exploring Co-occurring pole Exonuclease and Non-exonuclease Domain Mutations and Their Impact on Tumor Mutagenicity.
Shah SM; Demidova EV; Ringenbach S; Faezov B; Andrake M; Gandhi A; Mur P; Viana-Errasti J; Xiu J; Swensen J; Valle L; Dunbrack RL; Hall MJ; Arora S
Cancer Res Commun; 2024 Jan; 4(1):213-225. PubMed ID: 38282550
[TBL] [Abstract] [Full Text] [Related]
5. Prognosis of polymerase epsilon (pole) mutation in high-grade endometrioid endometrial cancer: Systematic review and meta-analysis.
Casanova J; Duarte GS; da Costa AG; Catarino A; Nave M; Antunes T; Serra SS; Dias SS; Abu-Rustum N; Lima J
Gynecol Oncol; 2024 Mar; 182():99-107. PubMed ID: 38262245
[TBL] [Abstract] [Full Text] [Related]
6. Predictive and prognostic biomarkers in female genital tract tumours: an update highlighting their clinical relevance and practical issues.
Wong RW; Cheung ANY
Pathology; 2024 Mar; 56(2):214-227. PubMed ID: 38212229
[TBL] [Abstract] [Full Text] [Related]
7. Management of Bilateral Diffuse Uveal Melanocytic Proliferation (BDUMP)-A Case Report.
Drača N; Orešković EG; Lazić R; Vukojević M; Radolović Bertetić A; Vukojević N
Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138261
[No Abstract] [Full Text] [Related]
8. Specific Pathology Features Enrich Selection of Endometrial Carcinomas for pole Testing.
Keyhanian K; Han L; Howitt BE; Longacre T
Am J Surg Pathol; 2024 Mar; 48(3):292-301. PubMed ID: 38062789
[TBL] [Abstract] [Full Text] [Related]
9. [Risk factor analysis of lymph node metastasis in endometrial carcinoma combined with molecular types].
Li LL; Li H; Li J; Zhang XB; Wang ZQ; Shen DH; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2023 Oct; 58(10):733-741. PubMed ID: 37849254
[No Abstract] [Full Text] [Related]
10. Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas.
Jamieson A; Vermij L; Kramer CJH; Jobsen JJ; Jürgemlienk-Schulz I; Lutgens L; Mens JW; Haverkort MAD; Slot A; Nout RA; Oosting J; Carlson J; Howitt BE; Ip PPC; Lax SF; McCluggage WG; Singh N; McAlpine JN; Creutzberg CL; Horeweg N; Gilks CB; Bosse T
Clin Cancer Res; 2023 Dec; 29(23):4949-4957. PubMed ID: 37773079
[TBL] [Abstract] [Full Text] [Related]
11. Molecular Classification of Endometrial Endometrioid Carcinoma With Microcystic Elongated and Fragmented Pattern.
Ju B; Wu J; Sun L; Yang C; Yu H; Hao Q; Wang J; Zhang H
Int J Gynecol Pathol; 2024 May; 43(3):233-241. PubMed ID: 37733028
[TBL] [Abstract] [Full Text] [Related]
12. Molecular subtypes of endometrial cancer: Implications for adjuvant treatment strategies.
Yang Y; Wu SF; Bao W
Int J Gynaecol Obstet; 2024 Feb; 164(2):436-459. PubMed ID: 37525501
[TBL] [Abstract] [Full Text] [Related]
13. High-grade Serous Carcinoma can Show Squamoid Morphology Mimicking True Squamous Differentiation.
Tomonobe H; Ohishi Y; Hachisuga K; Yahata H; Kato K; Oda Y
Am J Surg Pathol; 2023 Sep; 47(9):967-976. PubMed ID: 37382102
[TBL] [Abstract] [Full Text] [Related]
14. A comprehensive molecular analysis of 113 primary ovarian clear cell carcinomas reveals common therapeutically significant aberrations.
Stružinská I; Hájková N; Hojný J; Krkavcová E; Michálková R; Dvořák J; Němejcová K; Matěj R; Laco J; Drozenová J; Fabian P; Hausnerová J; Méhes G; Škapa P; Švajdler M; Cibula D; Frühauf F; Bártů MK; Dundr P
Diagn Pathol; 2023 Jun; 18(1):72. PubMed ID: 37303048
[TBL] [Abstract] [Full Text] [Related]
15. The Significance of International Federation of Gynecology and Obstetrics Grading in Microsatellite Instability-High and pole-Mutant Endometrioid Endometrial Carcinoma.
Kertowidjojo E; Momeni-Boroujeni A; Rios-Doria E; Abu-Rustum N; Soslow RA
Mod Pathol; 2023 Sep; 36(9):100234. PubMed ID: 37268062
[TBL] [Abstract] [Full Text] [Related]
16. Alteration in molecular properties during establishment and passaging of endometrial carcinoma patient-derived xenografts.
Imai T; Yoshida H; Machida Y; Kuramochi M; Ichikawa H; Kubo T; Takahashi M; Kato T
Sci Rep; 2023 May; 13(1):8511. PubMed ID: 37231035
[TBL] [Abstract] [Full Text] [Related]
17. "Surface epithelial slackening" pattern in endometrioid carcinoma: A morphological feature for differentiating the pole mutation-subtype from the no specific molecular profile subtype.
Kitazono I; Akahane T; Yokoyama S; Kobayashi Y; Togami S; Yanazume S; Tasaki T; Noguchi H; Tabata K; Kobayashi H; Tanimoto A
Pathol Res Pract; 2023 Jul; 247():154563. PubMed ID: 37229919
[TBL] [Abstract] [Full Text] [Related]
18. pole exonuclease domain mutations in endometrial carcinoma: a case report.
Pasciuto MP; Felicioni L; Zampacorta C; Ferro B; Di Marino P; Primavera FC; Lucidi A; Rossetti R; Barbareschi M; Marchetti A; Buttitta F; D'Angelo E
Pathologica; 2023 May; 1(1):181-185. PubMed ID: 37216304
[TBL] [Abstract] [Full Text] [Related]
19. Corded and hyalinized endometrioid carcinoma: Summary of clinical, histological, immunohistochemical and molecular data.
Travaglino A; Arciuolo D; Santoro A; Raffone A; Raimondo D; Casadio P; Seracchioli R; Fulgione C; Guida M; Mollo A; Inzani F; Zannoni GF
Pathol Res Pract; 2023 Jul; 247():154515. PubMed ID: 37209572
[TBL] [Abstract] [Full Text] [Related]
20. High-grade serous ovarian carcinoma with a sertoliform pattern associated with BRCA mutation: a clinicopathological and molecular analysis.
Travaglino A; Santoro A; Arciuolo D; Raffone A; Scaglione G; D'Alessandris N; Valente M; Sfregola S; Fulgione C; Onori ME; Minucci A; Zannoni GF
Virchows Arch; 2023 Dec; 483(6):879-883. PubMed ID: 37166561
[TBL] [Abstract] [Full Text] [Related]
[Next]